Management Information To be Supplied to CCS no later than the 7th of each month without fail. Report are to be submitted via MISO CCS Review 100% Failure to submit will fall in line with FA KPI FROM THE FOLLOWING, PLEASE SELECT AND OUTLINE YOUR CHARGING MECHANISM FOR THIS SOW. WHERE A CHARGING MECHANISM IS NOT REQUIRED, PLEASE REMOVE TEXT AND REPLACE WITH “UNUSED”. 5.1 CAPPED TIME AND MATERIAL CHARGES 5.2 PRICE PER STORY POINT CHARGES 5.3 TIME AND MATERIALS CHARGES
Enterprise Information Management Standards Performing Agency shall conform to HHS standards for data management as described by the policies of the HHS Chief Data and Analytics Officer. These include, but are not limited to, standards for documentation and communication of data models, metadata, and other data definition methods that are required by HHS for ongoing data governance, strategic portfolio analysis, interoperability planning, and valuation of HHS System data assets.
DEFECTIVE MANAGEMENT INFORMATION 5.1 The Supplier acknowledges that it is essential that the Authority receives timely and accurate Management Information pursuant to this Framework Agreement because Management Information is used by the Authority to inform strategic decision making and allows it to calculate the Management Charge.
Client Information Protected Health Information in any form including without limitation, Electronic Protected Health Information or Unsecured Protected Health Information (herein “PHI”);
Electronic and Information Resources Accessibility and Security Standards a. Applicability: The following Electronic and Information Resources (“EIR”) requirements apply to the Contract because the Grantee performs services that include EIR that the System Agency's employees are required or permitted to access or members of the public are required or permitted to access. This Section does not apply to incidental uses of EIR in the performance of the Agreement, unless the Parties agree that the EIR will become property of the State of Texas or will be used by HHSC’s clients or recipients after completion of the Agreement. Nothing in this section is intended to prescribe the use of particular designs or technologies or to prevent the use of alternative technologies, provided they result in substantially equivalent or greater access to and use of a Product.